(-0.09%) 5 142.25 points
(-0.03%) 38 548 points
(-0.07%) 17 892 points
(0.12%) $82.73
(2.41%) $2.08
(-1.23%) $2 328.80
(-2.42%) $26.99
(-1.03%) $951.60
(0.19%) $0.934
(0.40%) $11.03
(0.21%) $0.798
(-0.21%) $93.11
Live Chart Being Loaded With Signals
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom...
Stats | |
---|---|
今日成交量 | 644 688 |
平均成交量 | 759 144 |
市值 | 2.15M |
EPS | £0 ( 2024-04-03 ) |
Last Dividend | £18.00 ( 1997-05-19 ) |
Next Dividend | £0 ( N/A ) |
P/E | -0.800 |
ATR14 | £0.0350 (4.62%) |
N4 Pharma PLC 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
N4 Pharma PLC 财务报表
Annual | 2023 |
营收: | £1 953.00 |
毛利润: | £1 953.00 (100.00 %) |
EPS: | £-0.00520 |
FY | 2023 |
营收: | £1 953.00 |
毛利润: | £1 953.00 (100.00 %) |
EPS: | £-0.00520 |
FY | 2022 |
营收: | £0 |
毛利润: | £0 (0.00 %) |
EPS: | £-0.00550 |
FY | 2021 |
营收: | £0.00 |
毛利润: | £0.00 (0.00 %) |
EPS: | £-0.00850 |
Financial Reports:
No articles found.
N4 Pharma PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £16.00 | 1995-05-22 |
Last Dividend | £18.00 | 1997-05-19 |
Next Dividend | £0 | N/A |
Payout Date | 1997-07-01 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | £85.20 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.05 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
1995 | £0 | 0.00% |
1996 | £0 | 0.00% |
1997 | £0 | 0.00% |
1998 | £0 | 0.00% |
1999 | £0 | 0.00% |
2000 | £0 | 0.00% |
2001 | £0 | 0.00% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0 | 0.00% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSON.L | Dividend King | 2023-08-10 | Semi-Annually | 32 | 1.90% | |
GEC.L | Dividend Knight | 2023-09-25 | Quarterly | 22 | 0.24% | |
AJIT.L | Dividend Junior | 2023-09-14 | Semi-Annually | 16 | 1.25% | |
TND.L | Dividend Knight | 2023-05-11 | Semi-Annually | 31 | 1.44% | |
LUCE.L | Dividend Knight | 2023-09-14 | Annually | 8 | 2.16% | |
COST.L | Dividend Knight | 2023-09-21 | Annually | 17 | 0.27% | |
RST.L | Dividend Junior | 2023-09-21 | Annually | 13 | 0.98% | |
HIK.L | Dividend Knight | 2023-08-10 | Semi-Annually | 19 | 1.60% | |
AZN.L | Ex Dividend Knight | 2023-08-10 | Semi-Annually | 32 | 1.07% | |
VIC.L | Dividend Knight | 2023-06-08 | Semi-Annually | 2 | 0.88% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -649.94 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.995 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.987 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 14.86 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 14.73 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 12.57 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.00478 | 2.00 | -0.00159 | -0.00318 | [0 - 30] |
freeCashFlowPerShareTTM | -0.00478 | 2.00 | -0.00239 | -0.00478 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -729.44 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.00153 | 0.800 | -3.32 | -2.66 | [0.5 - 2] |
Total Score | -1.289 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -1.595 | 1.000 | -0.262 | 0 | [1 - 100] |
returnOnEquityTTM | -0.987 | 2.50 | -7.76 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.00478 | 2.00 | -0.00159 | -0.00478 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.00478 | 2.00 | -0.00159 | -0.00318 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -1.748 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -619.10 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -3.03 |
N4 Pharma PLC
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。